Fapon Biopharma specializes in discovering and developing biologics for treating cancers, autoimmune diseases and other diseases where there are unmet medical needs. We have built several drug discovery platforms, including an IL-10M Fusion Protein Platform(FILTEN), a Bi/Tri-TCE Platform, a Proteolysis Targeting intra-Nanobody (PROTiNb) platform and an antibody discovery platform based on the globally leading mammalian cell display technology. We have also built a differentiated pipeline of leading drug candidates. We have established capabilities that cover the entire drug development process from drug discovery, Chemistry, Manufacturing and Controls (CMC), preclinical research, to early clinical development. We are committed to offering quality innovative drugs to benefit better medicines for all.

Zhuhai Fapon Biopharma Co., Ltd. is a subsidiary of Guangdong Fapon Biopharma Co, Ltd., focusing on generating IL-10M fusion proteins.